Frederick W. Driscoll

Frederick W. Driscoll is recorded as Chairman at Lite Strategy, Inc. (LITS) since July 22, 2024, Board Member at Lite Strategy, Inc. (LITS) and Board Member at Cellectar Biosciences, Inc. (CLRB) since January 1, 2017. The newest filing on record that lists Frederick W. Driscoll as Board Member at Lite Strategy, Inc. (LITS) is dated December 30, 2025. The newest filing on record that lists Frederick W. Driscoll as Board Member at Cellectar Biosciences, Inc. (CLRB) is dated May 28, 2026. Earlier roles on record: Board Member at ImmunityBio, Inc. (IBRX) until March 29, 2021. Lite Strategy, Inc. reported in an 8-K filed July 22, 2024 that Frederick W. Driscoll was appointed Chairperson of the Company. Lite Strategy, Inc. reported in an 8-K filed February 23, 2023 that Frederick W. Driscoll resigned as Board of Directors. Cellectar Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Lite Strategy, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cellectar Biosciences, Inc. includes James Caruso (CEO and Board Member), James V. Caruso (CEO and Board Member), Douglas J. Swirsky (Chairman and Board Member) and 7 others.